SHINE and Phoenix strike deal
An exclusive, long-term agreement has been signed between SHINE Medical Technologies and Phoenix Nuclear Labs (PNL). The two companies have had a research and development partnership for five years. According to a release, the new agreement assures that SHINE will provide further funding for PNL to refine their neutron generator technology to meet the reliability requirements of the SHINE isotope production facility in Janesville. PNL will also supply all neutron generators required by SHINE’s Janesville facility through the length of the agreement.
SHINE is working to become a manufacturer of radioisotopes for nuclear medicine, specifically molybdenum-99. Phoenix Nuclear Labs has developed nuclear fusion technology with applications from medicine to national defense.